Skip to content

A clinical Study on Bronchial Asthma in children

A clinical study on the management of Tamaka Shwasa with special reference to Bronchial Asthma in children with Shwasahara Dashemani - TSSD

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/11/006340
Enrollment
40
Registered
2015-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diseased having signs and symptoms of bronchial asthma

Interventions

Intervention1: Shwasahara Dashemani churna with the sapta bhavana with the decoction of same Shwasahara dashemani drugs Reference Charaka Samhita Sutra sthana 4 chapter shlok no 37: Churna of eight he

Sponsors

DIRECTOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of 2 to 12 years of age of either sex Diagnosed cases of Tamaka Shwasa Bronchial Asthma with at least 2 episodes of asthma symptoms during the previous year Patients on other drug therapy will be included only after completion of wash out period of 3 weeks Patients or Parents or legal guardians willing to give written informed consent or assent

Exclusion criteria

Exclusion criteria: Children of age below 2 years and above the 12 years Evidence of active concomitants pulmonary disease other than asthma Evidence of requirement of intubations for asthma or had been hospitalized for asthma within one month before. Had unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 2 weeks Patients on active corticosteroid therapy or more than 4 short courses of oral corticosteroids within the year preceding the screening visit or any oral corticosteroids in the preceding 4 weeks Use of Astemizole Nedocromil Cromolyn long acting beta agonists Ketotifen or Theophylline within 2 weeks before Concomitant severe decompensated systemic disease cardiovascular renal hepatic endocrine hematological neurological immunological

Design outcomes

Primary

MeasureTime frame
Relieve in the sign and symptom of Shwasa Roga or Bronchial asthmaTimepoint: 8 weeks

Secondary

MeasureTime frame
To prevent the recurrence of attacks of breathlessness To increase the immunity against allergensTimepoint: 8 weeks

Countries

India

Contacts

Public ContactPROF KALPANA S PATEL

INSTITUTE FOR POSTGRADUATE TEACHING and RESEARCH IN AYURVEDA

drrajagopala@ayurveduniversity.com9426953318

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026